LFCR

Business Context and Reporting Period

This Form 10-Q covers the fiscal quarter ended February 25, 2007, for Landec Corporation (Note: The input metadata listed "LIFECORE BIOMEDICAL, INC.", but the filing text explicitly identifies the registrant as Landec Corporation). Landec designs, develops, and sells temperature-activated polymer products for food and agricultural applications. The company operates two primary segments: Food Products Technology (via subsidiary Apio, Inc.) and Agricultural Seed Technology (via subsidiary Landec Ag, Inc.).

Key Financial Metrics

Note: All figures in thousands except per share data.

Material Changes vs. Prior Period

• Significant Gain on Sale: The dramatic increase in Net Income and Operating Income is primarily driven by a one-time gain of $22.69 million recorded from the sale of Fielder's Choice Direct (FCD), the company's direct seed sales business, to American Seeds, Inc. (a subsidiary of Monsanto) on December 1, 2006.
• Revenue Decline in Ag Segment: Excluding the sale, Landec Ag revenues dropped significantly (down 84% for the quarter) because the FCD business, which generated the majority of agricultural revenue, was sold. Remaining Ag revenue is now derived from license fees and technology supply.
• Food Segment Growth: The Food Products Technology segment (Apio) saw revenue growth of 8% for the quarter and 4% for the nine-month period, driven by increased sales of value-added fresh-cut products and new product introductions.
• Expense Reduction: Selling, General, and Administrative (SG&A) expenses decreased by 33% for the quarter and 17% for the nine months, largely due to the elimination of FCD-related costs and a $1.5 million reduction in expenses from an insurance settlement.

Guidance, Outlook, and Risks

• Monsanto Agreement: Following the FCD sale, Landec entered a five-year co-exclusive technology license and supply agreement with Monsanto. This guarantees minimum payments of $17 million over five years, with potential buyout options increasing total payments to $21 million. Landec expects to recognize approximately $5.4 million in annual revenue from this agreement for fiscal years 2008–2011.
• Liquidity: Cash and cash equivalents increased to $58.3 million, a net increase of $37.8 million from the prior year-end, bolstered by the $50 million cash proceeds from the FCD sale.
• Customer Concentration: The top five customers accounted for approximately 50% of revenues for the nine months ended February 25, 2007. Costco Wholesale Corp. alone accounted for approximately 20% of revenues.
• Risks: Key risks include dependence on weather conditions affecting produce supply and pricing, reliance on single-source suppliers for raw materials, and the potential for product liability claims. The company also faces regulatory risks regarding food packaging materials under the FDA and environmental regulations.

Investor Verification Checklist

• Recurring vs. Non-Recurring Income: Verify the sustainability of earnings by excluding the $22.7 million one-time gain from the FCD sale to assess core operating profitability.
• Monsanto Contract Terms: Review the specific terms of the five-year license agreement with Monsanto, including the conditions for the $4 million termination fee or $8 million buyout option.
• Customer Concentration: Assess the risk associated with Costco Wholesale Corp. representing 20% of total revenue and the lack of long-term purchase agreements with major customers.
• Inventory Levels: Monitor inventory levels, particularly for Apio, as the company faces risks related to ordering packaging materials in advance of customer orders.
• Debt Status: Confirm that the revolving line of credit for Landec Ag was fully paid and terminated following the FCD sale, leaving only minimal long-term debt obligations.